HIGH TIDE INC (HITI.CA) Stock Fundamental Analysis

TSX-V:HITI • CA42981E4013

3.38 CAD
-0.01 (-0.29%)
Last: Feb 23, 2026, 07:00 PM
Fundamental Rating

3

Taking everything into account, HITI scores 3 out of 10 in our fundamental rating. HITI was compared to 33 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of HITI have multiple concerns. HITI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • HITI had negative earnings in the past year.
  • HITI had a positive operating cash flow in the past year.
  • In the past 5 years HITI always reported negative net income.
  • Of the past 5 years HITI 4 years had a positive operating cash flow.
HITI.CA Yearly Net Income VS EBIT VS OCF VS FCFHITI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

1.2 Ratios

  • The Return On Assets of HITI (-14.54%) is comparable to the rest of the industry.
  • HITI has a Return On Equity (-57.92%) which is in line with its industry peers.
  • With a decent Return On Invested Capital value of 4.71%, HITI is doing good in the industry, outperforming 78.79% of the companies in the same industry.
Industry RankSector Rank
ROA -14.54%
ROE -57.92%
ROIC 4.71%
ROA(3y)-11.05%
ROA(5y)-14.75%
ROE(3y)-30.28%
ROE(5y)-32.2%
ROIC(3y)N/A
ROIC(5y)N/A
HITI.CA Yearly ROA, ROE, ROICHITI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200 -250

1.3 Margins

  • HITI has a better Operating Margin (2.74%) than 72.73% of its industry peers.
  • HITI's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 25.99%, HITI is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of HITI has declined.
Industry RankSector Rank
OM 2.74%
PM (TTM) N/A
GM 25.99%
OM growth 3YN/A
OM growth 5Y10.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y-6.82%
HITI.CA Yearly Profit, Operating, Gross MarginsHITI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60 -80

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HITI is destroying value.
  • HITI has more shares outstanding than it did 1 year ago.
  • HITI has more shares outstanding than it did 5 years ago.
  • HITI has a worse debt/assets ratio than last year.
HITI.CA Yearly Shares OutstandingHITI.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
HITI.CA Yearly Total Debt VS Total AssetsHITI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of 1.64, we must say that HITI is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.64, HITI is in the better half of the industry, outperforming 78.79% of the companies in the same industry.
  • HITI has a debt to FCF ratio of 8.31. This is a slightly negative value and a sign of low solvency as HITI would need 8.31 years to pay back of all of its debts.
  • The Debt to FCF ratio of HITI (8.31) is better than 72.73% of its industry peers.
  • HITI has a Debt/Equity ratio of 0.94. This is a neutral value indicating HITI is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.94, HITI is doing worse than 72.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 8.31
Altman-Z 1.64
ROIC/WACC0.53
WACC8.81%
HITI.CA Yearly LT Debt VS Equity VS FCFHITI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • HITI has a Current Ratio of 1.37. This is a normal value and indicates that HITI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of HITI (1.37) is worse than 60.61% of its industry peers.
  • HITI has a Quick Ratio of 1.37. This is a bad value and indicates that HITI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HITI has a Quick ratio of 0.70. This is in the lower half of the industry: HITI underperforms 75.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.7
HITI.CA Yearly Current Assets VS Current LiabilitesHITI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

  • HITI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -884.13%.
  • The Revenue has grown by 13.72% in the past year. This is quite good.
  • The Revenue has been growing by 48.14% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-884.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
Revenue 1Y (TTM)13.72%
Revenue growth 3Y18.51%
Revenue growth 5Y48.14%
Sales Q2Q%18.61%

3.2 Future

  • The Earnings Per Share is expected to grow by 30.45% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 13.03% on average over the next years. This is quite good.
EPS Next Y121.5%
EPS Next 2Y60.32%
EPS Next 3Y46.8%
EPS Next 5Y30.45%
Revenue Next Year26.45%
Revenue Next 2Y21.62%
Revenue Next 3Y16.73%
Revenue Next 5Y13.03%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HITI.CA Yearly Revenue VS EstimatesHITI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
HITI.CA Yearly EPS VS EstimatesHITI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HITI. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 25.35 indicates a quite expensive valuation of HITI.
  • Based on the Price/Forward Earnings ratio, HITI is valued a bit cheaper than 66.67% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.75, HITI is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 25.35
HITI.CA Price Earnings VS Forward Price EarningsHITI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • 69.70% of the companies in the same industry are more expensive than HITI, based on the Enterprise Value to EBITDA ratio.
  • HITI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. HITI is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.49
EV/EBITDA 8.84
HITI.CA Per share dataHITI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as HITI's earnings are expected to grow with 46.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.32%
EPS Next 3Y46.8%

0

5. Dividend

5.1 Amount

  • HITI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

HIGH TIDE INC

TSX-V:HITI (2/23/2026, 7:00:00 PM)

3.38

-0.01 (-0.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)03-13
Inst Owners13.66%
Inst Owner ChangeN/A
Ins Owners8.85%
Ins Owner ChangeN/A
Market Cap297.24M
Revenue(TTM)593.99M
Net Income(TTM)-50.75M
Analysts80
Price Target7.31 (116.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.04%
Min Revenue beat(2)0.98%
Max Revenue beat(2)1.09%
Revenue beat(4)3
Avg Revenue beat(4)0.55%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.13%
Revenue beat(12)9
Avg Revenue beat(12)0.97%
Revenue beat(16)13
Avg Revenue beat(16)7.41%
PT rev (1m)-1.15%
PT rev (3m)-1.15%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.49%
Revenue NQ rev (1m)-0.41%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)-2.49%
Revenue NY rev (3m)-2.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.35
P/S 0.5
P/FCF 22.49
P/OCF 12.45
P/B 3.39
P/tB N/A
EV/EBITDA 8.84
EPS(TTM)-0.62
EYN/A
EPS(NY)0.13
Fwd EY3.94%
FCF(TTM)0.15
FCFY4.45%
OCF(TTM)0.27
OCFY8.03%
SpS6.75
BVpS1
TBVpS-0.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.54%
ROE -57.92%
ROCE 6.54%
ROIC 4.71%
ROICexc 5.83%
ROICexgc 16.38%
OM 2.74%
PM (TTM) N/A
GM 25.99%
FCFM 2.23%
ROA(3y)-11.05%
ROA(5y)-14.75%
ROE(3y)-30.28%
ROE(5y)-32.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y8.85%
ROICexc growth 3YN/A
ROICexc growth 5Y9.97%
OM growth 3YN/A
OM growth 5Y10.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y-6.82%
F-Score2
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 8.31
Debt/EBITDA 2.03
Cap/Depr 43.8%
Cap/Sales 1.79%
Interest Coverage 2.21
Cash Conversion 58.77%
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 0.7
Altman-Z 1.64
F-Score2
WACC8.81%
ROIC/WACC0.53
Cap/Depr(3y)33.59%
Cap/Depr(5y)35.25%
Cap/Sales(3y)1.64%
Cap/Sales(5y)2.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-884.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
EPS Next Y121.5%
EPS Next 2Y60.32%
EPS Next 3Y46.8%
EPS Next 5Y30.45%
Revenue 1Y (TTM)13.72%
Revenue growth 3Y18.51%
Revenue growth 5Y48.14%
Sales Q2Q%18.61%
Revenue Next Year26.45%
Revenue Next 2Y21.62%
Revenue Next 3Y16.73%
Revenue Next 5Y13.03%
EBIT growth 1Y6.44%
EBIT growth 3YN/A
EBIT growth 5Y64.03%
EBIT Next Year707.98%
EBIT Next 3Y142.78%
EBIT Next 5Y76.98%
FCF growth 1Y-48.76%
FCF growth 3YN/A
FCF growth 5Y16.8%
OCF growth 1Y-32.86%
OCF growth 3Y74.46%
OCF growth 5Y21.95%

HIGH TIDE INC / HITI.CA FAQ

What is the fundamental rating for HITI stock?

ChartMill assigns a fundamental rating of 3 / 10 to HITI.CA.


What is the valuation status for HITI stock?

ChartMill assigns a valuation rating of 4 / 10 to HIGH TIDE INC (HITI.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for HIGH TIDE INC?

HIGH TIDE INC (HITI.CA) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for HITI stock?

The Earnings per Share (EPS) of HIGH TIDE INC (HITI.CA) is expected to grow by 121.5% in the next year.